Clinical trial
Initial Diastolic Shock Index and Lactate as Predictors of Occult Vasoplegia in Normotensive Sepsis.
NCT07658014 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Initial Diastolic Shock Index and Lactate as Predictors of Occult Vasoplegia in Normotensive Sepsis.
- Lead sponsor
- Hospital H+ Queretaro
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- April 1, 2026
- Enrollment
- 526 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, septic shock, vasoplegia